Delivery Order SPE2DR25D1104-SPE2DR26FK983
- Not listed
- The Defense Logistics Agency (DLA) awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This competitively awarded, firm fixed-price contract is classified as a non-set-aside delivery order with performance to be completed by October 9, 2025, at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $7,298.00 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Gel-One 30 mg/3 mL syringes (3 mL quantity). The contract carries a firm fixed price structure with no set-aside designation and an ultimate completion date of October 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $1,153.65 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for GEL-ONE 30 mg/3 ml syringes (3 ml quantity). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 21, 2026. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,054.40 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565562938 - GEL-ONE 30 MG/3 ML SYRINGE 3ML, with a completion date of August 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies essential medical commodities, including prescription drugs, vaccines, and medical supplies, to various federal agencies and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $7,691.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on November 24, 2025. The contract, which carries a firm fixed price structure, is classified as a non-set-aside competitive award with an ultimate completion date of December 16, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 20, 2025, for Gel-One 30 mg/3 mL syringes valued at $10,947.00 through a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by September 11, 2025, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $11.5K delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by November 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same municipality....
- The Defense Logistics Agency awarded a delivery order valued at $19,227.50 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $7,691.00 for GEL-ONE 30 mg/3 mL syringes. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by November 21, 2025. The award was issued on October 30, 2025, and performance will be conducted at the awardee's Conshohocken facility. This delivery order is issued under AmerisourceBergen's...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK983Delivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,691.00 by the Defense Logistics Agency on January 20, 2026, for the supply of Gel-One 30 mg/3 mL syringes. The contract is a firm fixed-price, non-set-aside award with performance scheduled to be completed by February 10, 2026, with the place of performance located in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, demonstrating extensive capability in fulfilling diverse medical supply requirements across multiple therapeutic domains. The DLA, as part of the Department of Defense, procures essential medical commodities through prime vendor contracts to support military treatment facilities and healthcare programs worldwide. This specific delivery order represents routine procurement activity under the broader pharmaceutical prime vendor framework, which enables efficient sourcing of medical products to support military medical readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 1/19/26 |